A Settlement Conference has been scheduled for March 17, 2009 at 2:30 pm, EST, in the federal district courthouse in Trenton, New Jersey in the Clarinex®/(Descloratadine) Patent Litigation -- I expect that several of the already settling defendants will be dismissed outright, but that a decision to go to trial will be reached as to at least eight of them (background under that link). I'll provide a report on that day.
. . . .Minute Entry for proceedings held before Magistrate Judge Tonianne J. Bongiovanni:
Telephone Conference held on February 13, 2009 -- Settlement Conference set for March 18, 2009 02:30 PM in Trenton -- Courtroom 6E -- before Magistrate Judge Tonianne J. Bongiovanni. . . .
So -- will there be an at-risk generic launch in 2009? [The branded franchise drug is still worth over $750 million a year in sales to Schering.] My best-guess candidate to do so would be Orchid Pharmaceuticals, out of India. We'll have to wait and see.
No comments:
Post a Comment